Clinical Trial Update: Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports termination of antineoplaston therapy for children with primary malignant brain tumors. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Childhood Brain Tumor | Phase 2 | Status: TERMINATED | Results posted: 2017-04-10